A detailed history of American Century Companies Inc transactions in Hille Vax, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 17,176 shares of HLVX stock, worth $31,947. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,176
Previous 17,158 0.1%
Holding current value
$31,947
Previous $248,000 87.9%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.58 - $14.42 $28 - $259
18 Added 0.1%
17,176 $30,000
Q2 2024

Aug 07, 2024

BUY
$11.86 - $15.93 $11 - $15
1 Added 0.01%
17,158 $248,000
Q1 2024

May 14, 2024

BUY
$14.15 - $19.75 $68,825 - $96,064
4,864 Added 39.57%
17,157 $285,000
Q4 2023

Feb 13, 2024

BUY
$10.35 - $17.11 $127,232 - $210,333
12,293 New
12,293 $197,000

Others Institutions Holding HLVX

About HilleVax, Inc.


  • Ticker HLVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,427,200
  • Market Cap $62.2M
  • Description
  • HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
More about HLVX
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.